(Q41167388)

English

Long-term nonprogressor and elite controller patients who control viremia have a higher percentage of methylation in their HIV-1 proviral promoters than aviremic patients receiving highly active antiretroviral therapy

scientific article published on 12 September 2012

In more languages
default for all languages
No label defined

No description defined

Statements

Long-term nonprogressor and elite controller patients who control viremia have a higher percentage of methylation in their HIV-1 proviral promoters than aviremic patients receiving highly active antiretroviral therapy (English)
Juan Antonio Palacios
Teresa Pérez-Piñar
Beatriz Sanz-Minguela
Victoria Moreno
Eulalia Valencia
César Gómez-Hernando
Berta Rodés
12 September 2012
13081-13084

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit